A Versatile Technique for the In Vivo Imaging of Human Tumor Xenografts Using Near-Infrared Fluorochrome-Conjugated Macromolecule Probes

Here, we present a versatile method for detecting human tumor xenografts in vivo, based on the enhanced permeability and retention (EPR) effect, using near-infrared (NIR) fluorochrome-conjugated macromolecule probes. Bovine serum albumin (BSA) and two immunoglobulins—an anti-human leukocyte antigen (HLA) monoclonal antibody and isotype control IgG2a—were labeled with XenoLight CF770 fluorochrome and used as NIR-conjugated macromolecule probes to study whole-body imaging in a variety of xenotransplantation mouse models. NIR fluorescent signals were observed in subcutaneously transplanted BxPC-3 (human pancreatic cancer) cells and HCT 116 (colorectal cancer) cells within 24 h of NIR-macromolecule probe injection, but the signal from the fluorochrome itself or from the NIR-conjugated small molecule (glycine) injection was not observed. The accuracy of tumor targeting was confirmed by the localization of the NIR-conjugated immunoglobulin within the T-HCT 116 xenograft (in which the orange-red fluorescent protein tdTomato was stably expressed by HCT 116 cells) in the subcutaneous transplantation model. However, there was no significant difference in the NIR signal intensity of the region of interest between the anti-HLA antibody group and the isotype control group in the subcutaneous transplantation model. Therefore, the antibody accumulation within the tumor in vivo is based on the EPR effect. The liver metastasis generated by an intrasplenic injection of T-HCT 116 cells was clearly visualized by the NIR-conjugated anti-HLA probe but not by the orange-red fluorescent signal derived from the tdTomato reporter. This result demonstrated the superiority of the NIR probes over the tdTomato reporter protein at enhancing tissue penetration. In another xenograft model, patient-derived xenografts (PDX) of LC11-JCK (human non-small cell lung cancer) were successfully visualized using the NIR-conjugated macromolecule probe without any genetic modification. These results suggested that NIR-conjugated macromolecule, preferably, anti-HLA antibody probe is a valuable tool for the detection of human tumors in experimental metastasis models using whole-body imaging.

[1]  A. Vahrmeijer,et al.  Targeting integrins and enhanced permeability and retention (EPR) effect for optical imaging of oral cancer , 2012, Journal of surgical oncology.

[2]  U. Pastorino,et al.  Patient-Derived Xenografts of Non Small Cell Lung Cancer: Resurgence of an Old Model for Investigation of Modern Concepts of Tailored Therapy and Cancer Stem Cells , 2012, Journal of biomedicine & biotechnology.

[3]  Sharon Bloch,et al.  Near-infrared molecular probes for in vivo imaging. , 2012, Current protocols in cytometry.

[4]  Erlong Zhang,et al.  A review of NIR dyes in cancer targeting and imaging. , 2011, Biomaterials.

[5]  Kami Kim,et al.  Bright and stable near infra-red fluorescent protein for in vivo imaging , 2011, Nature Biotechnology.

[6]  M. Suematsu,et al.  The reconstituted 'humanized liver' in TK-NOG mice is mature and functional. , 2011, Biochemical and biophysical research communications.

[7]  Michael Z. Lin,et al.  Autofluorescent proteins with excitation in the optical window for intravital imaging in mammals. , 2009, Chemistry & biology.

[8]  Michael Z. Lin,et al.  Mammalian Expression of Infrared Fluorescent Proteins Engineered from a Bacterial Phytochrome , 2009, Science.

[9]  H. Maeda,et al.  Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[10]  K. Machida,et al.  Higher susceptibility of NOG mice to xenotransplanted tumors. , 2009, The Journal of toxicological sciences.

[11]  H. Fujii,et al.  Downregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma , 2008, British Journal of Cancer.

[12]  Vasilis Ntziachristos,et al.  Performance of the red-shifted fluorescent proteins in deep-tissue molecular imaging applications. , 2008, Journal of biomedical optics.

[13]  H. Suemizu,et al.  Liver metastasis models of colon cancer for evaluation of drug efficacy using NOD/Shi-scid IL2Rgammanull (NOG) mice. , 2008, International journal of oncology.

[14]  H. Suemizu,et al.  Identification of a key molecular regulator of liver metastasis in human pancreatic carcinoma using a novel quantitative model of metastasis in NOD/SCID/gammacnull (NOG) mice. , 2007, International journal of oncology.

[15]  Chun-Jung Chang,et al.  The Immunization Site of Cytokine-Secreting Tumor Cell Vaccines Influences the Trafficking of Tumor-Specific T Lymphocytes and Antitumor Efficacy against Regional Tumors1 , 2004, The Journal of Immunology.

[16]  Markus G. Manz,et al.  Development of a Human Adaptive Immune System in Cord Blood Cell-Transplanted Mice , 2004, Science.

[17]  M. Bibby,et al.  Orthotopic models of cancer for preclinical drug evaluation: advantages and disadvantages. , 2004, European journal of cancer.

[18]  B. Rice,et al.  Quantitative comparison of the sensitivity of detection of fluorescent and bioluminescent reporters in animal models. , 2004, Molecular imaging.

[19]  Meng Yang,et al.  Chronologically-specific metastatic targeting of human pancreatic tumors in orthotopic models , 2004, Clinical and Experimental Metastasis.

[20]  Robert M. Hoffman,et al.  Orthotopic Metastatic Mouse Models for Anticancer Drug Discovery and Evaluation: a Bridge to the Clinic , 2004, Investigational New Drugs.

[21]  H. Maeda,et al.  Macromolecular therapeutics: advantages and prospects with special emphasis on solid tumour targeting. , 2003, Clinical pharmacokinetics.

[22]  Mamoru Ito,et al.  NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. , 2002, Blood.

[23]  H. Shimada,et al.  Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Y. Fukushima,et al.  Growth stimulation of non-small cell lung cancer xenografts by granulocyte-macrophage colony-stimulating factor (GM-CSF). , 1998, European journal of cancer.

[25]  J. D. Di Santo,et al.  Enhanced human cell engraftment in mice deficient in RAG2 and the common cytokine receptor gamma chain. , 1998, British journal of haematology.

[26]  R. Rees,et al.  An immunohistochemical study of altered immunomodulatory molecule expression in head and neck squamous cell carcinoma. , 1997, British Journal of Cancer.

[27]  F. Esteban,et al.  Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer. , 1991, Seminars in cancer biology.

[28]  H. Maeda,et al.  A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.

[29]  I. Fidler,et al.  Metastatic behavior of tumor cells isolated from primary and metastatic human colorectal carcinomas implanted into different sites in nude mice. , 1986, Cancer research.